Lack of the serum- and glucocorticoid-inducible kinase SGK1 improves muscle force characteristics and attenuates fibrosis in dystrophic mdx mouse muscle

[1]  J. Spinazzola,et al.  Viral expression of insulin-like growth factor I E-peptides increases skeletal muscle mass but at the expense of strength. , 2014, American journal of physiology. Endocrinology and metabolism.

[2]  T. Hornberger,et al.  Faculty Opinions recommendation of Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. , 2014 .

[3]  R. Fink,et al.  Cardiac and Respiratory Dysfunction in Duchenne Muscular Dystrophy and the Role of Second Messengers , 2013, Medicinal research reviews.

[4]  Claudia K. Winkler,et al.  Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy , 2013, International journal of molecular medicine.

[5]  S. Takeda,et al.  Activation of calcium signaling through Trpv1 by nNOS and peroxynitrite as a key trigger of skeletal muscle hypertrophy , 2012, Nature Medicine.

[6]  L. Leinwand,et al.  Activation of serum/glucocorticoid-induced kinase 1 (SGK1) is important to maintain skeletal muscle homeostasis and prevent atrophy , 2012, EMBO molecular medicine.

[7]  A. Mamalis,et al.  NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents , 2013, Archives of Dermatological Research.

[8]  Jiangyang Zhang,et al.  Inhibition of myostatin reverses muscle fibrosis through apoptosis , 2012, Journal of Cell Science.

[9]  M. Vainzof,et al.  Differential Expression of Genes Involved in the Degeneration and Regeneration Pathways in Mouse Models for Muscular Dystrophies , 2012, NeuroMolecular Medicine.

[10]  E. Hoffman,et al.  The paradox of muscle hypertrophy in muscular dystrophy. , 2012, Physical medicine and rehabilitation clinics of North America.

[11]  J. Hagood,et al.  Myofibroblast differentiation and survival in fibrotic disease , 2011, Expert Reviews in Molecular Medicine.

[12]  Kristian Gundersen,et al.  Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise , 2011, Biological reviews of the Cambridge Philosophical Society.

[13]  A. Blamire,et al.  Molecular Pathogenesis of Genetic and Inherited Diseases Long-Term Blocking of Calcium Channels in mdx Mice Results in Differential Effects on Heart and Skeletal Muscle , 2010 .

[14]  山元 英樹.  Direct aldosterone action as a profibrotic factor via ROS-mediated SGK1 in peritoneal fibroblasts , 2011 .

[15]  H. Brinkmeier.  TRP channels in skeletal muscle: gene expression, function and implications for disease. , 2011, Advances in experimental medicine and biology.

[16]  S. Head.  Branched fibres in old dystrophic mdx muscle are associated with mechanical weakening of the sarcolemma, abnormal Ca2+ transients and a breakdown of Ca2+ homeostasis during fatigue , 2010, Experimental physiology.

[17]  D. Glass.  PI3 kinase regulation of skeletal muscle hypertrophy and atrophy. , 2010, Current topics in microbiology and immunology.

[18]  H. Brinkmeier,et al.  Functional TRPV4 channels are expressed in mouse skeletal muscle and can modulate resting Ca2+ influx and muscle fatigue , 2010, Pflügers Archiv - European Journal of Physiology.

[19]  M. Nowycky,et al.  Reciprocal amplification of ROS and Ca2+ signals in stressed mdx dystrophic skeletal muscle fibers , 2009, Pflügers Archiv - European Journal of Physiology.

[20]  Gregory Q. Wallace,et al.  Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. , 2009, Annual review of physiology.

[21]  C. Reggiani,et al.  Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle. , 2008, Human molecular genetics.

[22]  M. Takigawa,et al.  Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy , 2008, Journal of the Neurological Sciences.

[23]  V. Mezzano,et al.  Constitutively activated dystrophic muscle fibroblasts show a paradoxical response to TGF-β and CTGF/CCN2 , 2007, Journal of Cell Communication and Signaling.

[24]  G. D’Antona,et al.  T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse , 2007, The Journal of pathology.

[25]  T. Abraham,et al.  Myostatin does not regulate cardiac hypertrophy or fibrosis , 2007, Neuromuscular Disorders.

[26]  M. Georges,et al.  The RYR1 g.1843C>T mutation is associated with the effect of the IGF2 intron3-g.3072G>A mutation on muscle hypertrophy. , 2007, Animal genetics.

[27]  F Verrecchia,et al.  [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.

[28]  F. Lang,et al.  (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. , 2006, Physiological reviews.

[29]  F. Artunc,et al.  Serum- and Glucocorticoid-Inducible Kinase 1 Mediates Salt Sensitivity of Glucose Tolerance , 2006, Diabetes.

[30]  J. Ross,et al.  SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment , 2006, Journal of Molecular Medicine.

[31]  E. Barton,et al.  Systemic administration of L‐arginine benefits mdx skeletal muscle function , 2005, Muscle & nerve.

[32]  Y. Lecarpentier,et al.  Severe muscle dysfunction precedes collagen tissue proliferation in mdx mouse diaphragm. , 2003, Journal of applied physiology.

[33]  J. Tidball,et al.  Do immune cells promote the pathology of dystrophin-deficient myopathies? , 2001, Neuromuscular Disorders.

[34]  J. Faulkner,et al.  Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment , 2001, Neuromuscular Disorders.

[35]  H. Brinkmeier,et al.  Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. , 2000, Physiological reviews.

[36]  T. Partridge,et al.  T-Cell-Dependent Fibrosis in the mdx Dystrophic Mouse , 2000, Laboratory Investigation.

[37]  G. Butler-Browne,et al.  Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children , 2000, Neuromuscular Disorders.

[38]  E. Füchtbauer,et al.  Dmdmdx‐βgeo: A new allele for the mouse dystrophin gene , 1998 .

[39]  E. Füchtbauer,et al.  Dmd(mdx-beta geo): a new allele for the mouse dystrophin gene. , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[40]  Se-Jin Lee,et al.  Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member , 1997, nature.

[41]  L. Morandi,et al.  Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. , 1995, The Journal of clinical investigation.

[42]  R. Strohman,et al.  Fiber regeneration is not persistent in dystrophic (MDX) mouse skeletal muscle. , 1991, Developmental biology.

[43]  J. Shrager,et al.  The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy , 1991, Nature.

[44]  Judy E. Anderson.  Dystrophic changes in mdx muscle regenerating from denervation and devascularization , 1991, Muscle & nerve.

[45]  H. Blau,et al.  Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: Implications for cell and gene therapy , 1990, Somatic cell and molecular genetics.

[46]  J. Faulkner,et al.  Contractile properties of skeletal muscles from young, adult and aged mice. , 1988, The Journal of physiology.

[47]  T. Partridge,et al.  THE mdx MOUSE SKELETAL MUSCLE MYOPATHY: I. A HISTOLOGICAL, MORPHOMETRIC AND BIOCHEMICAL INVESTIGATION , 1988, Neuropathology and applied neurobiology.